N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer

N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer

Abstract Background Single-nucleotide polymorphisms (SNPs) in N6-methyladenosine (m6A) related genetic locus play significant roles in tumorigenesis and development. The expression level of many oncogenes and tumour suppressor genes changed because of m6A-associated SNPs. In addition, the relationsh...

Full description

Bibliographic Details
Main Authors:	Jiancheng Lv, Qiang Song, Kexin Bai, Jie Han, Hao Yu, Kai Li, Juntao Zhuang, Xiao Yang, Haiwei Yang, Qiang Lu
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Series:	Cancer Cell International
Subjects:	Bladder cancer Single-nucleotide polymorphisms N6-methyladenosine Ring finger protein Transmembrane 2 Proliferation
Online Access:	https://doi.org/10.1186/s12935-022-02701-z

Similar Items

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N 6-methyladenosine of Notch1
by: Chaohui Gu, et al.
Published: (2019-11-01)

Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer
by: Skender Saidi, et al.

N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges
by: Congjie Xu, et al.
Published: (2024-02-01)

N6-Methyladenosine-related alternative splicing events play a role in bladder cancer
by: Chang Yuan, et al.
Published: (2022-10-01)

CircPTPRA blocks the recognition of RNA N 6 -methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
by: Fei Xie, et al.
Published: (2021-04-01)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
by: Xin Huang, et al.
Published: (2022-08-01)

Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis
by: Hong-Miao Li, et al.
Published: (2022-08-01)

Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk
by: Maria Samara, et al.
Published: (2021-11-01)

Single nucleotide polymorphism mutation related genes in bladder cancer for the treatment of patients: a study based on the TCGA database
by: Tengyun Long, et al.
Published: (2021-01-01)

The emerging roles of N6-methyladenosine in osteoarthritis
by: Hui Liu, et al.
Published: (2022-11-01)

FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner
by: Zhuang Sun, et al.
Published: (2023-12-01)

Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase
by: Jinbo Huang, et al.
Published: (2018-03-01)

piRNA PROPER Suppresses DUSP1 Translation by Targeting N6‐Methyladenosine‐Mediated RNA Circularization to Promote Oncogenesis of Prostate Cancer
by: Shuai Ben, et al.
Published: (2024-09-01)

Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma
by: Patrik Palacka, et al.
Published: (2024-09-01)

Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties
by: Yugandhar Kothapalli, et al.
Published: (2024-05-01)

Potential roles of N6-methyladenosine (m6A) in immune cells
by: Chang Liu, et al.
Published: (2021-06-01)

Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy
by: Juntao Zhuang, et al.
Published: (2022-06-01)

SINEUP non-coding RNA activity depends on specific N6-methyladenosine nucleotides
by: Bianca Pierattini, et al.
Published: (2023-06-01)

N6‐methyladenosine‐modified lncRNA ARHGAP5‐AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma
by: Jiandong Liu, et al.
Published: (2022-11-01)

Insights into N6-methyladenosine and programmed cell death in cancer
by: Li Liu, et al.
Published: (2022-01-01)

Genome-Wide Identification of N6-Methyladenosine Associated SNPs as Potential Functional Variants for Type 1 Diabetes
by: Yang Chen, et al.
Published: (2022-06-01)

Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study
by: Di Jin, et al.
Published: (2020-05-01)

β-Elemene inhibits the proliferation and migration of human glioblastoma cell lines via suppressing ring finger protein 135
by: Alizada M, et al.
Published: (2020-08-01)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
by: Mingyang Ma, et al.
Published: (2022-11-01)

Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
by: Jiayi He, et al.
Published: (2023-04-01)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
by: Xiaoxin Xu, et al.
Published: (2023-11-01)

N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC
by: Tan C, et al.
Published: (2023-09-01)

Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects
by: Qianzi Liu, et al.
Published: (2024-03-01)

HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
by: Jiancheng Lv, et al.
Published: (2023-02-01)

The functions of N6-methyladenosine modification in lncRNAs
by: Rong-Zhang He, et al.
Published: (2020-12-01)

N6-methyladenosine modification contributes to respiratory syncytial virus infection
by: Zhu Li, et al.
Published: (2023-04-01)

Association between MKRN3 and LIN28B polymorphisms and precocious puberty
by: Bo Ram Yi, et al.
Published: (2018-07-01)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
by: Ze Zhang, et al.
Published: (2022-05-01)

Research advances on the mechanism of N6-methyladenosine modification in diabetic kidney disease
by: Jian-yu Chen, et al.
Published: (2024-12-01)

N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential
by: Fei Han
Published: (2024-02-01)

Role of N6-methyladenosine methylation in glioma: recent insights and future directions
by: Chunlin Li, et al.
Published: (2023-12-01)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
by: Wenjie Zhang, et al.
Published: (2022-07-01)

The topological model of NS4B and its TMD3 in duck TMUV proliferation
by: Bowen Jiang, et al.
Published: (2024-06-01)

Emerging roles of N6-methyladenosine in arsenic-induced toxicity
by: Rongxian Li, et al.
Published: (2024-11-01)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
by: Shanshan Wang, et al.
Published: (2021-01-01)